title: [Chronic morbidities of premature newborns].
abstract: The most important chronic morbidities of premature newborns, deeply influencing quality of life, are retinopathy of prematurity, bronchopulmonary dysplasia, intraventricular hemorrhage and periventricular leukomalacia. Since the rate of premature birth has not decreased in recent years in Hungary, and treatments of these end stage disorders are extremely difficult, prevention gains tremendous significance. Effective prevention is based on detailed knowledge of the pathophysiological mechanisms of these special diseases having multifactorial nature sharing several common risk factors, and one is the pathological angiogenesis. This sensitive system is affected by several stress situations which are the consequences of prematurity leading to abnormal vascular growth. After birth, relative hyperoxia, compared to intrauterine life, and decreasing concentrations of vascular growth factors result in vascular injury, moreover, may cause vessel apoptosis. The consequence of this phenomenon is the activation of hypoxia responsible genes resulting in robust pathological neovascularization and organ damage during the later phase. Saving normal angiogenesis and inhibiting reactive neovascularization may lead to better quality of life in these premature infants.
authors.affiliation: Debreceni Egyetem, Orvos- és Egészségtudományi Centrum Gyermekgyógyászati Intézet Debrecen Nagyerdei krt. 98. 4032.
authors.forename: György
authors.initials: G
authors.lastname: Balla
authors.forename: Miklós
authors.initials: M
authors.lastname: Szabó
mesh_terms: D001997:Bronchopulmonary Dysplasia / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D002543:Cerebral Hemorrhage / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D002552:Cerebral Ventricles; D002908:Chronic Disease; D004040:Dietary Carbohydrates / Q000378:metabolism; D005865:Gestational Age; D006801:Humans; D006814:Hungary / Q000453:epidemiology; D018496:Hyperoxia / Q000150:complications; D007231:Infant, Newborn; D007969:Leukomalacia, Periventricular / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D009389:Neovascularization, Pathologic / Q000150:complications*; D047928:Premature Birth / Q000453:epidemiology; D011788:Quality of Life; D012178:Retinopathy of Prematurity / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D012307:Risk Factors; D042461:Vascular Endothelial Growth Factor A / Q000187:drug effects / Q000378:metabolism
chemical_list: D004040:Dietary Carbohydrates; D042461:Vascular Endothelial Growth Factor A